EMHA migraine scoring system: A novel, valid, and reliable metric to capture severity, align with patients, and facilitate communication
Cephalalgia · 2026
DOI: 10.1177/03331024261471185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cephalalgia, 2026. Verfasst von Patricia Pozo-Rosich und 13 weiteren Autor:innen. Beteiligte Einrichtung: Headache Unit, Neurology Department, Vall d'Hebron University Hospital, Barcelona, Spain. Hauptthemen laut MEDLINE: Migraine Disorders, Severity of Illness Index. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Available instruments to quantify migraine-related disability, such as the Headache Impact Test (HIT-6) and Migraine Disability Assessment Test (MIDAS), have certain limitations (e.g., recall bias, overlooking interictal burden), and do not always facilitate patient-doctor communication. We developed a migraine scoring system, namely the European Migraine and Headache Alliance–Migraine Scoring System (EMHA-MSS) with the aim of improving patient communication with healthcare professionals.
Methods
Cross-sectional, descriptive, quantitative study conducted between June 2024 and March 2025. First, we used exhaustive diary registries from 319 Spanish-speaking patients for a pilot study (of whom n = 280 had complete HIT-6/MIDAS). Second, the EMHA-MSS was administered to a validation cohort of Spanish patients ( N = 504). Third, we undertook cross-language analyses using a separate English-language dataset from English-speaking patients ( N = 51). The pilot benchmarking analyses used an exploratory three-item version of the scale with different scoring, whereas the final psychometric analyses used the four-item EMHA-MSS.
Results
The EMHA-MSS demonstrated unidimensional structure with excellent Confirmatory Factor Analysis fit (Comparative Fit Index = 1.000, Tucker-Lewis Index = 1.000, Root Mean Square Error of Approximation = 0.000, Standardized Root Mean Residual = 0.003). Acute treatment reliability was identified as the main factor driving reclassification between severity categories when comparing EMHA-MSS and HIT-6 or MIDAS (comparisons used an exploratory 3-item EMHA-MSS with different scoring in the pilot cohort). Our model provided an excellent fit, supported the expected factorial structure, and demonstrated that factor scores could be reliably calculated. The EMHA-MSS showed good to excellent test-retest reliability. Cross-language validity was demonstrated for the English version using configural and metric invariance, as well as partial scalar invariance.
Conclusion
The EMHA-MSS highlighted the importance of treatment reliability, pain and attack intensity, and frequency in classifying patients with migraine and evaluating the severity of the disease. This novel scoring system could facilitate tailored management and monitoring of migraine over time, potentially improving alignment with patients’ perceptions and enhancing the understanding between them and healthcare providers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Headache Unit, Neurology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
- Headache and Neurological Pain Research Group, Departament de Medicina, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
- European Migraine and Headache Alliance (EMHA), Valencia, Spain.
- Department of Neurology, Danish Headache Center, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Department of Neurology, Headache Unit, University Clinic of Navarra, Pamplona, Spain.
ORCID-Profile: Patricia Pozo-Rosich, Edoardo Caronna, Messoud Ashina, Pablo Irimia, Dimos D Mitsikostas, Christian Lampl, Gisela M Terwindt, Peter J Goadsby
Zitieren
APA
Pozo-Rosich, P., Caronna, E., De La Torre, E. R., Ashina, M., Irimia, P., MaassenVanDenBrink, A., Mitsikostas, D. D., Lampl, C., Gil-Gouveia, R., Amin, F. M., Terwindt, G. M., Hurtado, D., Fairley, C., & Goadsby, P. J. (2026). EMHA migraine scoring system: A novel, valid, and reliable metric to capture severity, align with patients, and facilitate communication. Cephalalgia. https://doi.org/10.1177/03331024261471185
Vancouver
Pozo-Rosich P, Caronna E, De La Torre ER, Ashina M, Irimia P, MaassenVanDenBrink A, et al. EMHA migraine scoring system: A novel, valid, and reliable metric to capture severity, align with patients, and facilitate communication. Cephalalgia. 2026. doi:10.1177/03331024261471185
BibTeX
@article{PozoRosich2026,
author = {Pozo-Rosich, Patricia and Caronna, Edoardo and De La Torre, Elena Ruiz and Ashina, Messoud and Irimia, Pablo and MaassenVanDenBrink, Antoinette and Mitsikostas, Dimos D and Lampl, Christian and Gil-Gouveia, Raquel and Amin, Faisal Mohammad and Terwindt, Gisela M and Hurtado, David and Fairley, Carmen and Goadsby, Peter J},
title = {EMHA migraine scoring system: A novel, valid, and reliable metric to capture severity, align with patients, and facilitate communication},
journal = {Cephalalgia},
year = {2026},
doi = {10.1177/03331024261471185}
}
EUVIMED